Person:
GÜNAYDIN AKYILDIZ, AYŞENUR

Profile Picture
Google ScholarScopusORCIDPublons
Status
Organizational Units
Job Title
First Name
AYŞENUR
Last Name
GÜNAYDIN AKYILDIZ
Name
Email Address
Birth Date

Filters

20193
Reset filters

Settings

Author: Günaydın, Ayşenur × Item Type: Publication ×

Search Results

Now showing 1 - 3 of 3
  • Thumbnail Image
    PublicationOpen Access
    Celastrol pretreatment as a therapeutic option against cisplatin-induced nephrotoxicity
    (2019-09-01T00:00:00Z) Boran, Tuğçe; Günaydın, Ayşenur; Jannuzzı, Ayşe Tarbın; Özçağlı, Eren; Alpertunga, Büket; GÜNAYDIN AKYILDIZ, AYŞENUR
    Celastrol is a natural bioactive compound extracted from the medicinal plant Tripterygium wilfordii Hook F. It exhibits immunosuppressive, anti-inflammatory, and antioxidant activities. Cisplatin is a commonly used chemotherapeutic drug in the treatment of a wide range of tumors. Although very effective therapeutically, it can cause nephrotoxicity leading to dose reduction or discontinuation of treatment. This study aims to clarify the therapeutic potential of celastrol in cisplatin-induced nephrotoxicity. The possible protective effects of celastrol pretreatment against cisplatin-induced oxidative stress and genotoxicity were investigated. A rat kidney epithelial cell line NRK-52E was pretreated with the desired concentrations of celastrol (200 nM, 100 nM, and 50 nM) for 24 h. The cells were treated with 50 mu M cisplatin for a further 24 h to see whether cisplatin caused the same or less toxicity compared to the vehicle control group. Alkaline comet assay was performed for genotoxicity assessment. Genotoxicity evaluation revealed that celastrol caused a statistically significant reduction in DNA damage. Oxidative stress parameters were evaluated by measuring the glutathione (GSH) and protein carbonyl (PC) levels and also by measuring the enzyme activities of glutathione peroxidase (GPx), glutathione reductase (GR), catalase (CAT) and superoxide dismutase (SOD) enzymes. Celastrol pretreatment increased the GSH content of the cells and ameliorated the protein carbonylation level. Likewise, celastrol pretreatment improved the GR and CAT activities. However, no significant difference was observed in GPx and SOD activities. In the light of these findings, celastrol treatment could be a therapeutic option to reduce cisplatin-induced nephrotoxicity. Further studies are needed for the clarification of its therapeutic potential.
  • No Thumbnail Available
    PublicationMetadata only
    Thinking Mitochondrially; -Structural and Functional Alterations of Mitochondria in Chemically Induced Cytotoxicity- in the SOT 58th Annual Meeting and ToxExpo Program.
    (2019-03-01) Günaydın, Ayşenur; GÜNAYDIN AKYILDIZ, AYŞENUR
    -Structural and Functional Alterations of Mitochondria in Chemically Induced Cytotoxicity- in the SOT 58th Annual Meeting and ToxExpoProgram, March 10-14, 2019.
  • No Thumbnail Available
    PublicationMetadata only
    Cardiotoxicity Induced by Tyrosine Kinase Inhibitors
    (2019-10-16) Günaydın, Ayşenur; Boran, Tuğçe; Jannuzzı, Ayşe Tarbın; Alpertunga, Büket; GÜNAYDIN AKYILDIZ, AYŞENUR